Digital JournalEssential Science: New skin from gene therapyDigital JournalThe first ever treatment of a child, suffering with terrible skin damage, has been undertaken using transplants developed from genetically modified stem cells. The treatment was… Continue reading
European Biotechnology |
Roche chemo-immunotherapy combo mets NSCLC Phase III endpoint
European Biotechnology A Phase III study (IMpower150) sponsored by Roche has shown that a combo of the company’s PD-L1 blocker atezolizumab (Tecentriq) and VEGF blocking antibody bevacizumab (Avastin) plus paclitaxel + carboplatin vs Avastim plus chemotherapy … Roche announces trial successes in cancer, haemophiliaNasdaq UPDATE 3-Roche shares climb after trial wins in cancer, haemophiliaReuters |
The Telegraph |
Texas man with eyesight issues hopes gene therapy can help
The Telegraph The doctors used a pioneering treatment known as gene therapy, which has the potential to fix mistakes in patients’ DNA. The first gene therapy was approved in August for childhood leukemia, and a second, for lymphoma, won approval in November. |
The Telegraph |
Texas man with eyesight issues hopes gene therapy can help
The Telegraph The doctors used a pioneering treatment known as gene therapy, which has the potential to fix mistakes in patients’ DNA. The first gene therapy was approved in August for childhood leukemia, and a second, for lymphoma, won approval in November. |
BusinessKorea |
Korean Biotech Industry Begins to Develop CAR–T Therapeutic Drug
BusinessKorea The Korean biotech industry joined competition to develop a chimeric antigen receptor-T cell (CAR-T) therapeutic drug called “the cancer drug of doctors’ dream.” CAR-T is a technology that allows T cells which are a kind of common immune cells in blood … |
BusinessKorea |
Korean Biotech Industry Begins to Develop CAR–T Therapeutic Drug
BusinessKorea The Korean biotech industry joined competition to develop a chimeric antigen receptor-T cell (CAR-T) therapeutic drug called “the cancer drug of doctors’ dream.” CAR-T is a technology that allows T cells which are a kind of common immune cells in blood … |